Impact of boost radiation in the treatment of ductal carcinoma in situ: A population-based analysis

International Journal of Radiation Oncology Biology Physics

Volumn 86, Issue 3, 2013, Pages 491-497

  Rakovitch, Eileen ^a,b,c   Narod, Steven A ^c,d   Nofech Moses, Sharon ^a,c   Hanna, Wedad ^a,c   Thiruchelvam, Deva ^b   Saskin, Refik ^b   Taylor, Carole ^b   Tuck, Alan ^e   Youngson, Bruce ^f   Miller, Naomi ^f   Done, Susan J ^f   Sengupta, Sandip ^g   Elavathil, Leela ^c,h   Jani, Prashant A ^c,i   Bonin, Michel ^d   Metcalfe, Stephanie ^a   Paszat, Lawrence ^a,b,c  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b WOMEN S COLLEGE HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d LONDON HEALTH SCIENCES CENTRE   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f KINGSTON GENERAL HOSPITAL   (Canada)

^g HENDERSON GENERAL HOSPITAL   (Canada)

^h Regional Health Sciences Centre   (Canada)

ⁱ SUDBURY REGIONAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PATIENT TREATMENT; RADIOTHERAPY; SURGERY;

BREAST CONSERVING SURGERY; DUCTAL CARCINOMA IN SITU; LOCAL RECURRENCE; LOCAL RECURRENCE FREE; METHODS AND MATERIALS; MULTI VARIABLES; POPULATION STUDIES; SURVIVAL ANALYSIS;

RADIATION;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; DATA BASE; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MIDDLE AGED; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RECURRENT DISEASE; ADJUVANT THERAPY; AGED; ANALYSIS OF VARIANCE; BREAST TUMOR; CANADA; DISEASE FREE SURVIVAL; FOLLOW UP; MEDICAL STAFF; METHODOLOGY; PATHOLOGY; RADIATION DOSE FRACTIONATION; RETREATMENT; SEGMENTAL MASTECTOMY; STATISTICS; SURVIVAL; TREATMENT OUTCOME; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY, SEGMENTAL; MEDICAL STAFF, HOSPITAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ONTARIO; RADIOTHERAPY, ADJUVANT; RETREATMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

MLCS; MLOWN;

EID: 84880600874     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.02.031     Document Type: Article

References (21)

1. Page DL, Dupont WD, Rogers LW, et al. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 1995;76: 1197-1200.
2. Wapnir IL, Dignam JJ, Fisher B, et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 2011; 103:478-488.
3. Correa C, McGale P, Taylor C, et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 2010;2010:162-177.
4. Bijker N, Meijnen P, Peterse JL, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853da study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 2006;24:3381-3387.
5. Emdin SO, Granstrand B, Ringberg A, et al. SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening. Acta Oncol 2006;45:536-543.
6. Cuzick J, Sestak I, Pinder SE, et al. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: Long-term results from the UK/ANZ DCIS trial. Lancet Oncol 2011;12:21-29.
7. Viani GA, Stefano EJ, Afonso SL, et al. Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: A meta-analysis of randomized trials. Radiat Oncol 2007;2:28.
8. Vicini FA, Kestin LL, Goldstein NS, et al. Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breastconserving therapy. J Clin Oncol 2000;18:296-306.
9. Bijker N, Peterse JL, Duchateau L, et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinomain- situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001;19:2263-2271.
10. Omlin A, Amichetti M, Azria D, et al. Boost radiotherapy in young women with ductal carcinoma in situ: A multicentre, retrospective study of the Rare Cancer Network. Lancet Oncol 2006;7:652-656.
11. Bartelink H, Horiot JC, Poortmans P, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001;345:1378-1387.
12. Wong P, Lambert C, Agnihotram RV, et al. Ductal carcinoma in situdthe influence of the radiotherapy boost on local control. Int J Radiat Oncol Biol Phys 2012;82:e153-e158.
13. Yerushalmi R, Sulkes A, Mishaeli M, et al. Radiation treatment for ductal carcinoma in situ (DCIS): Is a boost to the tumor bed necessary' Neoplasma 2006;53:507-510.
14. Wai ES, Lesperance ML, Alexander CS, et al. Effect of radiotherapy boost and hypofractionation on outcomes in ductal carcinoma in situ. Cancer 2011;117:54-62.
15. Julian TB, Land SR, Wang Y, et al. Is boost therapy necessary in the treatment of DCIS' J Clin Oncol 2008;26.
16. Clarke EA, Marrett LD, Kreiger N. Cancer registration in Ontario: A computer approach. IARC Sci Publ 1991;95:246-257.
17. Currie AM, Fricke T, Gawne A, et al. Automated extraction of freetext from pathology reports. AMIA Annu Symp Proc 2006;899.
18. Julian TB, Land SR, Wang Y, et al. Is boost therapy necessary in the treatment of DCIS' J Clin Oncol 2008;28.
19. Whelan TJ, Pignol JP, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010; 362:513-520.
20. TROG (Trans Tasman Radiation Oncology Group) Cancer Research. Active TROG Trials, TROG 07.01 A randomized phase III study of radiation doses and fractionation schedules in non-low risk ductal carcinoma in situ (DCIS) of the breast. Available at: http://www.trog. com.au/Default.aspx'tabidZ71 Access date: November 2012.
21. Azria D, Cowen D, Bourgier C, et al. Phase III randomized French multicentric study to evaluate the impact of a localized 16-Gy boost after conservative surgery and a 50-Gy whole-breast irradiation in breast ductal carcinoma in situ (the BONBIS trial). J Clin Oncol 2011;29.